Trial Profile
A Pilot Study to Evaluate the Safety and Efficacy of Mycophenolate Sodium (Myfortic) in Combination With Sirolimus (Rapamune) in Stable Renal Allograft Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Mycophenolate sodium; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms MYFIIRP
- 02 Oct 2020 Status changed from recruiting to completed.
- 30 Jun 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 18 Sep 2009 Planned end date changed from 1 Dec 2008 to 1 Mar 2011 as reported by ClinicalTrials.gov.